Sign In
Buy SNY
$43.75
-0.230 (-0.523%)
At Close: Jul 21, 2026
Sanofi to buy Provention Bio in deal worth $2.9 billion
02:49am, Monday, 13'th Mar 2023
French pharmaceutical group Sanofi said Monday that it will buy Provention Bio, Inc., a U.S.-based biopharmaceutical company focused on autoimmune diseases, for $25 per share in cash, in a deal with a
5 Large Drug Stocks to Watch as Sector Picks Up in 2023
09:11am, Thursday, 09'th Mar 2023
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sa
International Wide-Moat Stocks On Sale - The March 2023 Heat Map
12:56am, Wednesday, 08'th Mar 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
7 Blue-Chip Stocks to Buy for Quality-Focused Investors
04:17pm, Monday, 06'th Mar 2023
When the game's on the line, sometimes you need to call up your most experienced players, which segues into this discussion of blue-chip stocks to buy. Any sports fan realizes that age comes for every
Sanofi Could Be on a Roll With a Strong Performance and Its Latest FDA Approval
07:05am, Monday, 06'th Mar 2023
Altuviiio is indicated to prevent and control bleeding episodes in hemophilia patients. In 2022, Sanofi saw business EPS grow more than 17% year over year.
5 Stocks With Amazingly Low EV-to-EBITDA Ratios to Snap Up
06:47am, Monday, 27'th Feb 2023
We have screened value stocks JKS, UFPI, ASX, BBCP and SNY based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Sanofi gets FDA approval for hemophilia drug
01:55am, Friday, 24'th Feb 2023
By Adria Calatayud
Where To Invest $10,000 Right Now?
08:47am, Tuesday, 21'st Feb 2023
This article is built around one key question: Where would you put $10,000 right now? I started by assessing the parameters of this question and presented interesting value-adding answers for my Twitt
SNY vs. NVO: Which Stock Should Value Investors Buy Now?
12:48pm, Friday, 17'th Feb 2023
SNY vs. NVO: Which Stock Is the Better Value Option?
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
New Strong Buy Stocks for February 7th
09:02am, Tuesday, 07'th Feb 2023
DLAKY, UBS, SNY, EVR and TME have been added to the Zacks Rank #1 (Strong Buy) List on February 7, 2022.
SNY Stock: 2.58% Decrease Explained
06:33am, Monday, 06'th Feb 2023
The stock price of Sanofi (NASDAQ: SNY) fell by 2.58% in the most recent trading session. This is why.
Sanofi SA (SNY) Q4 2022 Earnings Call Transcript
03:08pm, Friday, 03'rd Feb 2023
Sanofi SA (NASDAQ:SNY ) Q4 2022 Results Conference Call February 3, 2023 8:00 AM ET Company Participants Eva Schaefer-Jansen - Head, IR Paul Hudson - CEO Bill Sibold - EVP, Specialty Care and Presiden
Regeneron Pharma Outplays Fourth-Quarter Decline, But Sanofi Stock Topples
09:02am, Friday, 03'rd Feb 2023
Regeneron Pharma beat quarterly forecasts Friday, but its partner Sanofi posted a mixed report. Regeneron stock rose as SNY stock toppled.
Stocks to Watch in Europe: Chipmakers, Sanofi, Zur Rose
03:47am, Friday, 03'rd Feb 2023
Bloomberg's Joe Easton has a rundown of the stocks to keep an eye on in Europe today, including pharma firms Sanofi and Zur Rose, and chipmakers ASML, Infineon, and STMicroelectronics. Follow Bloomber
